IBD Therapy Infliximab Tested in Pediatric Patients 7 and Under

IBD Therapy Infliximab Tested in Pediatric Patients 7 and Under
A recent study entitled “Infliximab therapy in pediatric patients 7 years of age and younger” reports that infliximab therapy is less efficient in treating inflammatory bowel disease in children aged less than 7 years old when compared to its effect in older children. The study was published in the Journal of Pediatric Gastroenterology & Nutrition. Inflammatory bowel disease

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *